Ae Wealth Management LLC Crispr Therapeutics Ag Transaction History

Ae Wealth Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $252,574 - $472,057	6,540 Added 121.86%	11,907 $745,000
Q3 2023 Oct 11, 2023	SELL	$45.39 - $59.0 $80,975 - $105,256	-1,784 Reduced 24.95%	5,367 $243,000
Q2 2023 Jul 10, 2023	BUY	$43.47 - $67.77 $112,239 - $174,982	2,582 Added 56.51%	7,151 $401,000
Q1 2023 Apr 14, 2023	BUY	$41.0 - $56.12 $187,329 - $256,412	4,569 New	4,569 $206,000
Q3 2022 Oct 25, 2022	SELL	$61.1 - $83.78 $32,810 - $44,989	-537 Reduced 10.04%	4,810 $314,000
Q2 2022 Aug 03, 2022	BUY	$43.23 - $73.83 $52,092 - $88,965	1,205 Added 29.09%	5,347 $325,000
Q1 2022 Apr 18, 2022	SELL	$53.19 - $79.24 $70,370 - $104,834	-1,323 Reduced 24.21%	4,142 $260,000
Q4 2021 Jan 20, 2022	SELL	$70.09 - $111.29 $101,209 - $160,702	-1,444 Reduced 20.9%	5,465 $414,000
Q3 2021 Nov 01, 2021	BUY	$110.2 - $156.64 $214,118 - $304,351	1,943 Added 39.13%	6,909 $773,000
Q2 2021 Jul 21, 2021	BUY	$100.84 - $161.89 $7,663 - $12,303	76 Added 1.55%	4,966 $804,000
Q1 2021 Apr 27, 2021	SELL	$110.72 - $210.04 $1.08 Million - $2.05 Million	-9,772 Reduced 66.65%	4,890 $596,000
Q4 2020 Feb 01, 2021	BUY	$79.67 - $173.23 $274,224 - $596,257	3,442 Added 30.68%	14,662 $2.25 Million
Q3 2020 Nov 06, 2020	BUY	$78.5 - $100.64 $880,770 - $1.13 Million	11,220 New	11,220 $938,000
Q2 2020 Aug 05, 2020	SELL	$38.5 - $76.05 $193,077 - $381,390	-5,015 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$33.68 - $62.53 $168,905 - $313,587	5,015 New	5,015 $213,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.